eXoZymes, Inc. (EXOZ) es una empresa que cotiza en bolsa en el Salud sector, operando dentro de la Biotecnología industria. La empresa tiene su sede en Monrovia, NV, United States. El CEO actual es Michael Heltzen.
EXOZ tiene fecha de IPO 2024-11-13, 31 empleados a tiempo completo, cotiza en el NASDAQ Global Market, una capitalización de mercado de $91.91M.
eXoZymes, Inc. operates as a synthetic biochemical company in the United States. The company develops SimplePath, a platform that produces chemicals, including pharmaceuticals, fuels, materials, food additives, and novel compounds. Its platform also comprises one or more module which consist of one or more enzymes that work together to perform a defined biocatalytic conversion. The company was founded in 2014 and is headquartered in Monrovia, California.
